{"title":"应用Box-Behnken设计响应面法研究盐酸苯尼地平缓释片缓释模式的优化处方变量","authors":"Amaresh Prusty, B. K. Gupta, Amiyakanta Mishra","doi":"10.2174/2210303112666220329154050","DOIUrl":null,"url":null,"abstract":"\n\nIn this research study, an attempt has been made using Box–Behnken design (BBD) Response Surface Methodology to find optimized formulation variables at their 3 levels (Low, medium and high) to affect the dependent response which is % drug release pattern at different time intervals in extending drug release of Benidipine Hydrochloride(BH) matrix tablets. BH extended release tablets reduce the side effects associated with multiple dosing used during conventional tablets.\n\n\n\nAs in the preliminary work, we have found the most profound formulation factors for extending drug release of BH matrix tablets are Eudragit RS 100 amount (X1), HPMC K 100 M (X2), chitosan amount (X3), which we selected as independent factors at their low and high levels for this study considering % drug release at three different time intervals i.e. R1 (% of drug release in 2hr), R2 (% of drug release in 15hr) and R3 (% of drug release in 18hr) as dependent variables using dissolution media of phosphate buffer pH 6.8 with 75rpm.\n\n\n\nFrom the experimental runs of prepared tablets as predicted by Design Expert software, the model shows a quadratic equation due to less p value, and a very less difference was observed between adjusted R2 and predicted values R2in all selected responses which we considered as % drug release.\n\n\n\nThereforeby using the graphical response surface plot of BBD software,the optimized formulation of BH extended release tablet of Eudragit RS 100, HPMC K 100 M, Chitosan containing an amount of 45mg , 105 mg, and 45.71 mg respectively which shows an extended drug release of more than 18 hr. For constructing a satisfying fit of the model for the optimized formulation, result analysis was carried out for the internally studentized residuals versus the experimental runs indicating all data points are placed within the limits and the values of the predicted and actual response of each run were normally distributed near a straight line.\n","PeriodicalId":11310,"journal":{"name":"Drug Delivery Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of Box–Behnken Design Response Surface Methodology to Study Optimized Formulation Variables on Drug Release Pattern of Benidipine Hydrochloride Extended Release Matrix Tablet\",\"authors\":\"Amaresh Prusty, B. K. Gupta, Amiyakanta Mishra\",\"doi\":\"10.2174/2210303112666220329154050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nIn this research study, an attempt has been made using Box–Behnken design (BBD) Response Surface Methodology to find optimized formulation variables at their 3 levels (Low, medium and high) to affect the dependent response which is % drug release pattern at different time intervals in extending drug release of Benidipine Hydrochloride(BH) matrix tablets. BH extended release tablets reduce the side effects associated with multiple dosing used during conventional tablets.\\n\\n\\n\\nAs in the preliminary work, we have found the most profound formulation factors for extending drug release of BH matrix tablets are Eudragit RS 100 amount (X1), HPMC K 100 M (X2), chitosan amount (X3), which we selected as independent factors at their low and high levels for this study considering % drug release at three different time intervals i.e. R1 (% of drug release in 2hr), R2 (% of drug release in 15hr) and R3 (% of drug release in 18hr) as dependent variables using dissolution media of phosphate buffer pH 6.8 with 75rpm.\\n\\n\\n\\nFrom the experimental runs of prepared tablets as predicted by Design Expert software, the model shows a quadratic equation due to less p value, and a very less difference was observed between adjusted R2 and predicted values R2in all selected responses which we considered as % drug release.\\n\\n\\n\\nThereforeby using the graphical response surface plot of BBD software,the optimized formulation of BH extended release tablet of Eudragit RS 100, HPMC K 100 M, Chitosan containing an amount of 45mg , 105 mg, and 45.71 mg respectively which shows an extended drug release of more than 18 hr. For constructing a satisfying fit of the model for the optimized formulation, result analysis was carried out for the internally studentized residuals versus the experimental runs indicating all data points are placed within the limits and the values of the predicted and actual response of each run were normally distributed near a straight line.\\n\",\"PeriodicalId\":11310,\"journal\":{\"name\":\"Drug Delivery Letters\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Delivery Letters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/2210303112666220329154050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2210303112666220329154050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
摘要
在本研究中,尝试使用Box-Behnken设计(BBD)响应面方法,在三个水平(低、中、高)上寻找优化的配方变量,以影响盐酸贝尼地平(BH)基质片在不同时间间隔的依赖性反应,即%药物释放模式。BH缓释片可减少常规片剂中多次给药的副作用。在前期工作中,我们发现延长BH基质片药物释放的最深刻的配方因素是Eudragit RS 100量(X1)、HPMC K 100 M(X2)、壳聚糖量(X3),考虑到三个不同时间间隔的药物释放%,即R1(2小时内药物释放的%),R2(15小时内药物释放的%)和R3(18小时内药物的%)作为因变量,使用pH 6.8的磷酸盐缓冲液的溶出介质,75rpm。根据Design Expert软件预测的制备片剂的实验运行,由于p值较小,该模型显示出二次方程,并且在我们认为为药物释放%的所有选择的反应中,在调整的R2和预测值R2之间观察到非常小的差异。因此,利用BBD软件的图形响应面图,对Eudragit RS 100、HPMC K 100 M、壳聚糖BH缓释片的优化处方进行了研究,其缓释量分别为45mg、105mg和45.71mg,显示出超过18小时的缓释效果,对内部学生化残差与实验运行进行了结果分析,表明所有数据点都在限制范围内,并且每次运行的预测和实际响应值正态分布在直线附近。
Application of Box–Behnken Design Response Surface Methodology to Study Optimized Formulation Variables on Drug Release Pattern of Benidipine Hydrochloride Extended Release Matrix Tablet
In this research study, an attempt has been made using Box–Behnken design (BBD) Response Surface Methodology to find optimized formulation variables at their 3 levels (Low, medium and high) to affect the dependent response which is % drug release pattern at different time intervals in extending drug release of Benidipine Hydrochloride(BH) matrix tablets. BH extended release tablets reduce the side effects associated with multiple dosing used during conventional tablets.
As in the preliminary work, we have found the most profound formulation factors for extending drug release of BH matrix tablets are Eudragit RS 100 amount (X1), HPMC K 100 M (X2), chitosan amount (X3), which we selected as independent factors at their low and high levels for this study considering % drug release at three different time intervals i.e. R1 (% of drug release in 2hr), R2 (% of drug release in 15hr) and R3 (% of drug release in 18hr) as dependent variables using dissolution media of phosphate buffer pH 6.8 with 75rpm.
From the experimental runs of prepared tablets as predicted by Design Expert software, the model shows a quadratic equation due to less p value, and a very less difference was observed between adjusted R2 and predicted values R2in all selected responses which we considered as % drug release.
Thereforeby using the graphical response surface plot of BBD software,the optimized formulation of BH extended release tablet of Eudragit RS 100, HPMC K 100 M, Chitosan containing an amount of 45mg , 105 mg, and 45.71 mg respectively which shows an extended drug release of more than 18 hr. For constructing a satisfying fit of the model for the optimized formulation, result analysis was carried out for the internally studentized residuals versus the experimental runs indicating all data points are placed within the limits and the values of the predicted and actual response of each run were normally distributed near a straight line.